Femtrace FDA Approval History
FDA Approved: Yes (Discontinued) (First approved August 20, 2004)
Brand name: Femtrace
Generic name: estradiol acetate
Dosage form: Tablets
Company: Warner Chilcott
Treatment for: Postmenopausal Symptoms
Marketing Status: Discontinued
Femtrace (estradiol) is an oral estrogen indicated for the relief of postmenopausal vasomotor symptoms.
Development Timeline for Femtrace
|Aug 20, 2004||Femtrace Warner Chilcott - Treatment for Menopausal Vasomotor Symptoms|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.